Tecnología aplicada a la diabetes
Dublin Core
Título
Tecnología aplicada a la diabetes
Descripción
En la 17º Conferencia Internacional del ATTD 2024 los temas centrales fueron el diagnóstico de diabetes tipo 1 en etapas preclínicas y los aportes de la tecnología en diabetes tipo 2. Además, el rol de la inteligencia artificial en las nuevas opciones de monitoreo.
Autor
Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial
Fuente
I. Martens T, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin. A randomized clinical trial. JAMA 2021;325(22):2262-2272.
II, Carlson AL, et al. Flash glucose monitoring in type 2 patients managed with basal insulin in USA. BMJ Open Diabetes Res Care 2022;10(1):e002590.
III. Guerci B, et al. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technol Ther 2023 Jan;25(1):20-30.
IV. Miller E, et al. FreeStyle Libre improves HbA1c in people receiving GLP-1 therapy for type 2 diabetes. ATTD Conference, March 6-9, 2024, Florence, Italy.
V. Wright E, et al. Initiating GLP-1 therapy in combination with FreeStyle Libre provides greater benefit compared to GLP-1 alone. ATTD Conference, March 6-9, 2024, Florence, Italy.
VI. Choe HG, et al. Effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring in patients with type 2 diabetes. Results from the randomized open-label PDF study. Diabetes Care 2022;45(10):2224-2230.
II, Carlson AL, et al. Flash glucose monitoring in type 2 patients managed with basal insulin in USA. BMJ Open Diabetes Res Care 2022;10(1):e002590.
III. Guerci B, et al. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technol Ther 2023 Jan;25(1):20-30.
IV. Miller E, et al. FreeStyle Libre improves HbA1c in people receiving GLP-1 therapy for type 2 diabetes. ATTD Conference, March 6-9, 2024, Florence, Italy.
V. Wright E, et al. Initiating GLP-1 therapy in combination with FreeStyle Libre provides greater benefit compared to GLP-1 alone. ATTD Conference, March 6-9, 2024, Florence, Italy.
VI. Choe HG, et al. Effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring in patients with type 2 diabetes. Results from the randomized open-label PDF study. Diabetes Care 2022;45(10):2224-2230.
Editor
Editorial Lugones
Fecha
8 abril, 2024
Colaborador
Sanofi
Derechos
Sello Editorial Lugones
Relación
https://lugoneseditorial.com.ar/destacada/tecnologia-diabetes/
Formato
Digital
Idioma
Español
Tipo
Artículo científico
Identificador
Hyperlink Item Type Metadata
Colección
Citación
Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial, “Tecnología aplicada a la diabetes,” Sello Editorial Lugones, consulta 3 de noviembre de 2025, https://ciencia.lugoneseditorial.com.ar/items/show/6.